Vitamin D ile Koroner Kollateral Seviyesi Arasındaki İlişki

Amaç: Literatürde koroner kollateral dolaşımın (KKD) derecesi ile D vitamini seviyesi arasında muhtemel bir ilişki olabileceğine dair yayınlar mevcuttur. Bu çalışmanın amacı kronik total oklüzyon (KTO) nedeniyle perkütan koroner girişim yapılan hastalarda hem Rentrop hem de Werner sınıflandırmasına göre KKD ile D vitamini seviyesi arasında bir ilişki olup olmadığının araştırılmasıdır. Materyal-Metot: Mevcut çalışma tek-merkezli, retrospektif kohort çalışmasıdır. KTO işlemi için hastaneye yatırılan ardışık 101 hasta çalışmaya alınmıştır. Hastalar KKD derecesine göre hem Rentrop hem de Werner sınıflandırmasına göre üçer gruba ayrılmıştır. Her bir grup 25(OH)VitD3 seviyesine göre birbiriyle kıyaslanmıştır. Bulgular: Hastalar Rentrop sınıflandırmasına göre üç gruba ayrıldığında gruplar arasında 25(OH)VitD3 seviyesi açısından fark saptanmamıştır [Rentrop 1: 15,7 ng/ml (7,0-77,0 ng/ ml), Rentrop 2: 16,9 ng/ml (7,0-71,3), Rentrop 3: 16,6 ng/ ml (7,0-28,7), p=0,925]. Hastalar Werner sınıflandırmasına göre tekrar üç gruba sınıflandırıldığında yine gruplar arasında 25(OH)VitD3 seviyesi açısından fark saptanmamıştır [Werner 0: 19,6 ng/ml (7,0-77,0 ng/ml), Werner 1: 16,6 ng/ml (7,0- 71,3), Werner 2: 17,0 ng/ml (7,0-28,3), p=0,411]. Sonuç: Çalışma sonucuna göre 25(OH)VitD3 seviyesi ile KKD derecesi arasında klinik pratikte bire bir ilişki olmadığı kanaatindeyiz.

The Relation Between The Grade of Coronary Collaterals and Vitamin D Levels

Objective: There have been studies which revealed a possiblerelation with the grade of coronary collateral circulation (CCC)and the level of Vitamin D in the literature. The objective ofthis study was to assess whether there is a correlation betweenthe grade of CCC and the level of Vitamin D according to bothRentrop and Werner classifications in patients with coronarychronic total occlusion (CTO) who underwent percutaneouscoronary intervention.Material-Method: The present study is a single-centre,retrospective cohort study. A total of 101 consecutive patients,who were hospitalized to undergo coronary CTO procedure, wereenrolled in the study. The patients were classified into 3 groupswith regard to the grade of CCC according to both Rentrop andWerner classifications. These groups were compared with eachother according to the 25(OH)VitD3 levels.Results: There was no significant difference among 3 groupswith regard to 25(OH)VitD3 levels when the patients wereclassified according to the Rentrop classification [Rentrop 1:15.7 ng/ml (7.0-77.0 ng/ml), Rentrop 2: 16.9 ng/ml (7.0-71.3),Rentrop 3: 16.6 ng/ml (7.0-28.7), p=0.925]. Moreover, therewas no significant difference among 3 groups with regardto 25(OH)VitD3 levels when the patients were classifiedaccording to the Werner classification. [Werner 0: 19.6 ng/ml(7.0-77.0 ng/ml), Werner 1: 16.6 ng/ml (7.0-71.3), Werner 2:17.0 ng/ml (7.0-28.3), p=0.411].Conclusions: We deem that there may not be a direct correlation(one-to-one relationship) between the level of 25(OH)VitD3 andthe grade of CCC in clinical practice.

___

  • 1. Holick MF. Vitamin D: importance in prevention of cancers, type 1 diabetes, heart disease and osteoporosis. Am J Clin Nutr 2004; 79: 362-71.
  • 2. Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 2011; 29: 636-45.
  • 3. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008; 168: 1174- 80.
  • 4. Pilz S, Marz W, Wellnitz B, Seelhorst U, Fahrleitner- Pammer A, Dimai HP, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008; 93: 3927-35.
  • 5. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340-9.
  • 6. Sabia PJ, Powers ER, Ragosta M, SarembockI J, Burwell LR, Kaul S. An Association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992; 327: 1825–31.
  • 7. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Hata T, et al. Comparison of the cardioprotective effect of prodromal angina pectoris and collateral circulation in patients with a first anterior wall acute myocardial infarction. Am J Cardiol 2005; 95: 622–5.
  • 8. Rentrop KP, Thornton JC, Feit F, Van Buskirk M. Determinants and protective potential of coronary arterial collaterals as assessed by an angioplasty model. Am J Cardiol 1988; 61: 677-84.
  • 9. Werner GS, Ferrari M, Heinke S, Kuethe F, Surber R, Richartz BM, et al. Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions. Circulation 2003; 107: 1972-7.
  • 10. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-95.
  • 11. Werner GS, Ferrari M, Betge S, Gastmann O, Richartz BM, Figulla HR. Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion. Circulation 2001; 104: 2784-90.
  • 12. Seiler C, Engler R, Berner L, Stoller M, Meier P, Steck H, et al. Prognostic relevance of coronary collateral function: confounded or causal relationship? Heart 2013; 99: 1408-14.
  • 13. Meier P, Hemingway H, Lansky AJ, Knapp G, Pitt B, Seiler C. The impact of the coronary collateral circulation on mortality: a meta-analysis. Eur Heart J 2012; 33: 614-21.
  • 14. Cai WJ, Kocsis E, Luo X, Schaper W, Schaper J. Expression of endothelial nitric synthase in the vascular wall during arteriogenesis. Mol Cell Biochem 2004; 264: 193-200.
  • 15. Pittarella P, Squarzanti DF, Molinari C, Invernizzi M, Uberti F, Reno F. NO-dependent proliferation and migration induced by vitamin D in HUVEC. J Steroid Biochem Mol Biol 2015; 149: 35-42.
  • 16. Grundmann M, Haidar M, Placzko S, Niendorf R, Darashchonak N, Hubel CA, et al. Vitamin D improves the angiogenic properties of endothelial progenitor cells. Am J Physiol Cell Physiol 2012; 303: 954-62.
  • 17. Holick MF. Vitamin deficiency. N Engl J Med. 2007; 357: 266-81.
  • 18. Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC, et al. Synthesis of 1,25-dihydroxyvitamin D-3 by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 2002; 13: 621-9.
  • 19. Rebsamen MC, Sun JX, Norman AW, Liao JK. 1 Alpha, 25-dihydroxyvitamin D-3 induces vascular smooth muscle cell migration via activation ofphosphatidylinositol 3-kinase. Circ Res 2002; 91: 17-24.
  • 20. Cardus A, Parisi E, Gallego C, Aldea M, Fernandez E, Valdivielso JM. 1,25-dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGFmediated pathway. Kidney Int 2006; 69: 1377-84.
  • 21. Sahin I, Okuyan E, Gungor B, Elitok A, Umman S, Umman B, et al. Lower vitamin D level is associated with poor coronary collateral circulation. Scand Cardiovasc J 2014; 48: 278-83.
  • 22. Dogan Y, Sarli B, Baktir AO, Kurtul S, Akpek M, Sahin O, et al. 25-Hydroxy-vitamin D level may predict presence of coronary collaterals in patients with chronic coronary total occlusion. Postepy Kardiol Interwencyjnej 2015; 11: 191-6.
  • 23. Werner GS. The role of coronary collaterals in chronic total occlusions. Curr Cardiol Rev 2014; 10: 57-64.
  • 24. Shen Y, Ding FH, Dai Y, Wang XQ, Zhang RY, Lu L, et al. Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion. Cardiovasc Diabetol 2018; 17: 26.
  • 25. Sezer M, Ozcan M, Okcular I, Elitok A, Umman S, Umman B, et al. A potential evidence to explain the reason behind the devastating prognosis of coronary artery disease in uraemic patients: renal insufficiency is associated with poor coronary collateral vessel development. Int J Cardiol 2007; 115: 366-72.
  • 26. Turhan H, Yasar AS, Erbay AR, Yetkin E, Sasmaz H, Sabah I. Impaired coronary collateral vessel development in patients with metabolic syndrome. Coron Artery Dis 2005; 16: 281-5.
  • 27. Uysal OK, Sahin DY, Duran M, Turkoglu C, Yildirim A, Elbasan Z, et al. Association between uric acid and coronary collateral circulation in patients with stable coronary artery disease. Angiology 2014; 65: 227-31.
  • 28. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 2001; 49: 554-60.
Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi-Cover
  • ISSN: 2146-247X
  • Yayın Aralığı: Yılda 3 Sayı
  • Başlangıç: 2010
  • Yayıncı: Zehra ÜSTÜN